Add this result to my export selection Butterfly iQ+ for diagnostic ultrasound imaging - medtech innovation briefing (MIB254) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 04 March 2021 NICE has developed a medtech innovation briefing (MIB) on Butterfly iQ+ for diagnostic ultrasound imaging Read Summary Type: Evidence Summaries (Remove filter)
Add this result to my export selection Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis - evidence summary (ES35) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 24 February 2021 Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis Type: Evidence Summaries (Remove filter)
Add this result to my export selection COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (update) Source: National Institute for Health and Care Excellence - NICE (Remove filter) Published by National Institute for Health and Care Excellence, 24 February 2021 This evidence summary has been updated at the request of NHS England, because new evidence was identified: prepublication study results from the nationally prioritised RECOVERY platform study and a... Read Summary Type: Evidence Summaries (Remove filter) Type: Medicines Current Awareness (Add filter)
Add this result to my export selection Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis – evidence summary (ED35) Source: National Institute for Health and Care Excellence - NICE (Remove filter) Published by National Institute for Health and Care Excellence, 24 February 2021 This evidence summary focuses on the license extension for Crohn's disease and ulcerative colitis. Remsima (SC) can be self-administered at home if the person, family member or carer is given... Read Summary Type: Evidence Summaries (Remove filter) Type: Medicines Current Awareness (Add filter)
Add this result to my export selection The STAK tool for preventing and treating knee stiffness - medtech innovation briefing (MIB252) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 09 February 2021 NICE has developed a medtech innovation briefing (MIB) on the STAK tool for preventing and treating knee stiffness Read Summary Type: Evidence Summaries (Remove filter)
Add this result to my export selection PROPEL sinus implants for maintaining sinus patency after surgery - medtech innovation briefing (MIB253) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 09 February 2021 NICE has developed a medtech innovation briefing (MIB) on PROPEL sinus implants for maintaining sinus patency after surgery Read Summary Type: Evidence Summaries (Remove filter)
Add this result to my export selection moorLDLS-BI for burn depth assessment - medtech innovation briefing (MIB251) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 09 February 2021 NICE has developed a medtech innovation briefing (MIB) on moorLDLS-BI for burn depth assessment Read Summary Type: Evidence Summaries (Remove filter)
Add this result to my export selection URO17 for detecting bladder cancer - medtech innovation briefing (MIB250) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 04 February 2021 NICE has developed a medtech innovation briefing (MIB) on URO17 for detecting bladder cancer Read Summary Type: Evidence Summaries (Remove filter)
Add this result to my export selection DOAC Dipstick for detecting direct oral anticoagulants - medtech innovation briefing (MIB248) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 02 February 2021 NICE has developed a medtech innovation briefing (MIB) on DOAC Dipstick for detecting direct oral anticoagulants Read Summary Type: Evidence Summaries (Remove filter)
Add this result to my export selection CytoSorb for reducing risk of bleeding during cardiac surgery - medtech innovation briefing (MIB249) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 02 February 2021 NICE has developed a medtech innovation briefing (MIB) on CytoSorb for reducing risk of bleeding during cardiac surgery Read Summary Type: Evidence Summaries (Remove filter)